Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glomerulonephritis.

W G Couser1

  • 1University of Washington, Department of Medicine, UWMC, Seattle 98195, USA. wge@u.washington.edu

Lancet (London, England)
|May 8, 1999
PubMed
Summary
This summary is machine-generated.

This review covers glomerulonephritis diagnoses like poststreptococcal glomerulonephritis and IgA nephropathy, noting limited specific therapies. New treatments targeting inflammation mediators are emerging for these kidney diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

World kidney day 2011: protect your kidneys, save your heart.

International journal of organ transplantation medicine·2014
Same author

World Kidney Day 2011: protect your kidneys, save your heart.

Internal medicine journal·2012
Same author

Meeting report on the Bellagio Conference 'prevention of vascular diseases in the emerging world: An approach to global health equity'.

Kidney international·2006
Same author

Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

Intravenous immunoglobulin protects against experimental thrombotic microangiopathy.

Kidney international·2001
Same author

Complement (C5b-9) induces DNA synthesis in rat mesangial cells in vitro.

Kidney international·2001

Area of Science:

  • Nephrology
  • Immunology

Background:

  • Glomerulonephritis without systemic disease presents diagnostic challenges.
  • Key types include poststreptococcal glomerulonephritis, IgA nephropathy, rapidly progressive glomerulonephritis (RPGN), and membranoproliferative glomerulonephritis (MPGN).

Purpose of the Study:

  • To outline the differential diagnosis of non-systemic glomerulonephritis.
  • To discuss the underlying mechanisms and current therapeutic approaches for these conditions.

Main Methods:

  • Review of current understanding of glomerulonephritis pathogenesis.
  • Analysis of existing and developing treatment strategies.

Main Results:

  • Poststreptococcal glomerulonephritis and IgA nephropathy lack effective disease-specific therapies.

Related Experiment Videos

  • RPGN treatment involves steroids, cytotoxic drugs, and plasma exchange for specific types.
  • Hepatitis C-related MPGN shows improvement with antiviral therapies.

    • Conclusions:

    • While some glomerulonephritides have limited specific treatments, advancements in understanding disease mediators are paving the way for novel therapies.
    • Emerging treatments target cytokines, growth factors, and fibrin deposition, alongside improved immunotherapies.